Literature DB >> 21587267

The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations.

Ingo Vernaleken1, Lisa Peters, Mardjan Raptis, Robert Lin, Hans-Georg Buchholz, Yun Zhou, Oliver Winz, Frank Rösch, Peter Bartenstein, Dean F Wong, Wolfgang M Schäfer, Gerhard Gründer.   

Abstract

The high-affinity radioligand [(18)F]fallypride (FP) is frequently used for quantification of striatal/extrastriatal D(2/3) receptors and the receptor occupancies of antipsychotics (APs). Its 110 minutes half-life allows long scan durations. However, the optimum scan duration is a matter of debate. This investigation focuses on scan-duration-related effects on simplified reference tissue model (SRTM) results and the time point of transient equilibrium in a large sample of dynamic FP positron emission tomography (PET) scans. Fifty drug-free and 50 AP-treated subjects underwent FP-PET scans (180 minutes scan duration). The binding potential (BP(ND)) of the putamen, thalamus, and temporal cortex were calculated using the SRTM and the transient equilibrium model. Furthermore, receptor occupancies were calculated for AP-treated patients. Transient equilibrium in the unblocked putamen occurred after 121±29.6 minutes. The transient equilibrium occurred much earlier in the extrastriatal regions or under AP treatment. Stepwise scan shortening caused BP(ND) underestimations of 0.58% for the first 10-minute reduction (putamen, SRTM), finally reaching 5.76% after 1 hour scan-time reduction. We observed preferential extrastriatal AP binding irrespective of the analytical method. [(18)F]fallypride scan durations of 180 minutes reliably reach equilibrium even in D(2/3)-receptor-rich regions. Moderate reductions in FP scan durations only caused small changes to SRTM results even in receptor-rich regions. Apparently, the D(2/3) receptor occupancy results of APs, especially preferential extrastriatal binding observations, are not relevantly biased by inappropriate scan durations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21587267      PMCID: PMC3185884          DOI: 10.1038/jcbfm.2011.73

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  24 in total

1.  Bithalamical deep brain stimulation in tourette syndrome is associated with reduction in dopaminergic transmission.

Authors:  Ingo Vernaleken; Jens Kuhn; Doris Lenartz; Mardjan Raptis; Wolfgang Huff; Hildegard Janouschek; Irene Neuner; Wolfgang M Schaefer; Gerhard Gründer; Volker Sturm
Journal:  Biol Psychiatry       Date:  2009-08-26       Impact factor: 13.382

Review 2.  Neuroreceptor imaging studies in schizophrenia.

Authors:  W Gordon Frankle
Journal:  Harv Rev Psychiatry       Date:  2007 Sep-Oct       Impact factor: 3.732

3.  Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.

Authors:  Mark Slifstein; Lawrence S Kegeles; Xiaoyan Xu; Judy L Thompson; Nina Urban; John Castrillon; Elizabeth Hackett; S-A Bae; Marc Laruelle; Anissa Abi-Dargham
Journal:  Synapse       Date:  2010-05       Impact factor: 2.562

4.  Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.

Authors:  H Olsson; L Farde
Journal:  Neuroimage       Date:  2001-10       Impact factor: 6.556

5.  Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.

Authors:  Ingo Vernaleken; Hildegard Janouschek; Mardjan Raptis; Sandra Hellmann; Tanja Veselinovic; Anno Bröcheler; Christian Boy; Paul Cumming; Christoph Hiemke; Frank Rösch; Wolfgang M Schäfer; Gerhard Gründer
Journal:  Int J Neuropsychopharmacol       Date:  2010-04-15       Impact factor: 5.176

6.  Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.

Authors:  Yoko Ikoma; Hiroshi Ito; Ryosuke Arakawa; Masaki Okumura; Chie Seki; Miho Shidahara; Hidehiko Takahashi; Yuichi Kimura; Iwao Kanno; Tetsuya Suhara
Journal:  Neuroimage       Date:  2008-06-10       Impact factor: 6.556

7.  The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters.

Authors:  R Buchert; F Thiele
Journal:  Nuklearmedizin       Date:  2008       Impact factor: 1.379

8.  Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).

Authors:  Ingo Vernaleken; Christine Fellows; Hildegard Janouschek; Anno Bröcheler; Tanja Veselinovic; Christian Landvogt; Christian Boy; Hans-Georg Buchholz; Katja Spreckelmeyer; Peter Bartenstein; Paul Cumming; Christoph Hiemke; Frank Rösch; Wolfgang Schäfer; Dean F Wong; Gerhard Gründer
Journal:  J Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.153

9.  High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Authors:  Nicholas T Vandehey; Jeffrey M Moirano; Alexander K Converse; James E Holden; Jogesh Mukherjee; Dhanabalan Murali; R Jerry Nickles; Richard J Davidson; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-30       Impact factor: 6.200

10.  Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

Authors:  Robert M Kessler; Neil D Woodward; Patrizia Riccardi; Rui Li; M Sib Ansari; Sharlett Anderson; Benoit Dawant; David Zald; Herbert Y Meltzer
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

View more
  16 in total

1.  Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates.

Authors:  Rasmus M Birn; Alexander K Converse; Abigail Z Rajala; Andrew L Alexander; Walter F Block; Alan B McMillan; Bradley T Christian; Caitlynn N Filla; Dhanabalan Murali; Samuel A Hurley; Rick L Jenison; Luis C Populin
Journal:  J Neurosci       Date:  2018-12-10       Impact factor: 6.167

2.  Cocaine cue-induced dopamine release in the human prefrontal cortex.

Authors:  Michele S Milella; Aryandokht Fotros; Paul Gravel; Kevin F Casey; Kevin Larcher; Jeroen A J Verhaeghe; Sylvia M L Cox; Andrew J Reader; Alain Dagher; Chawki Benkelfat; Marco Leyton
Journal:  J Psychiatry Neurosci       Date:  2016-08       Impact factor: 6.186

3.  Synthesis and imaging validation of [¹⁸F]MDL100907 enabled by Ni-mediated fluorination.

Authors:  Hong Ren; Hsiao-Ying Wey; Martin Strebl; Ramesh Neelamegam; Tobias Ritter; Jacob M Hooker
Journal:  ACS Chem Neurosci       Date:  2014-06-03       Impact factor: 4.418

4.  The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18F]fallypride.

Authors:  Yo-Han Joo; Jeong-Hee Kim; Young-Don Son; Hang-Keun Kim; Yeon-Jeong Shin; Sang-Yoon Lee; Jong-Hoon Kim
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-16       Impact factor: 5.270

5.  The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region.

Authors:  Kenji Ishibashi; Chelsea L Robertson; Mark A Mandelkern; Andrew T Morgan; Edythe D London
Journal:  Mol Imaging       Date:  2013 Nov-Dec       Impact factor: 4.488

6.  Measuring extrastriatal dopamine release during a reward learning task.

Authors:  Elske Vrieze; Jenny Ceccarini; Diego A Pizzagalli; Guy Bormans; Mathieu Vandenbulcke; Koen Demyttenaere; Koen Van Laere; Stephan Claes
Journal:  Hum Brain Mapp       Date:  2011-11-23       Impact factor: 5.038

7.  Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation.

Authors:  Christin Y Sander; Joseph B Mandeville; Hsiao-Ying Wey; Ciprian Catana; Jacob M Hooker; Bruce R Rosen
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

8.  Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [¹⁸F]fallypride study in cocaine dependent participants.

Authors:  Aryandokht Fotros; Kevin F Casey; Kevin Larcher; Jeroen A J Verhaeghe; Sylvia M L Cox; Paul Gravel; Andrew J Reader; Alain Dagher; Chawki Benkelfat; Marco Leyton
Journal:  Neuropsychopharmacology       Date:  2013-04-01       Impact factor: 7.853

9.  Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18F]fallypride PET.

Authors:  Christopher T Smith; Linh C Dang; Leah L Burgess; Scott F Perkins; M Danica San Juan; Darcy K Smith; Ronald L Cowan; Nam T Le; Robert M Kessler; Gregory R Samanez-Larkin; David H Zald
Journal:  Psychopharmacology (Berl)       Date:  2018-10-22       Impact factor: 4.530

10.  A regularized full reference tissue model for PET neuroreceptor mapping.

Authors:  Joseph B Mandeville; Christin Y M Sander; Hsiao-Ying Wey; Jacob M Hooker; Hanne D Hansen; Claus Svarer; Gitte M Knudsen; Bruce R Rosen
Journal:  Neuroimage       Date:  2016-06-27       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.